DAN JONES, MD, PhD
Dr Jones is Medical Director of Cancer Diagnostics for Quest Diagnostics Nichols Institute (Chantilly, Virginia) and oversees surgical pathology, hematopathology, cytology, molecular oncology, flow cytometry and cytogenetics. In that role, he also spends far too much time fretting over the challenges facing diagnostic pathology in an era of declining reimbursements but the paradoxically unlimited expectations for personalized medicine.
In a previous life, Dan was a Professor in the Department of Hematopathology at The University of Texas M. D. Anderson Cancer Center in Houston, where he was Medical Director of the Molecular Diagnostics Laboratory, director of the Molecular Genetic Pathology Fellowship, and a researcher with interest in cutaneous T-cell lymphoma, melanoma and design of new agents and biomarker discovery for targeted therapies of cancer. He received his M.D. and Ph.D. from Case Western Reserve University, and did his residency at the Brigham and Women’s Hospital, with post-doctoral work at Harvard Medical School in chemokine biology with Tim Springer. He is boarded in Anatomic Pathology, Hematology, and Molecular Genetic Pathology.
His diagnostic interests include the integration of molecular testing and genomics into the routine diagnostic workup of lymphoma, leukemias and various solid tumors. He is the editor of a text, Neoplastic Hematopathology, which similarly explores the intersection of molecular diagnostics, clinical treatment and diagnostic pathology with a major focus on cutaneous lymphomas. Dan served as an executive board member of the Society for Hematopathology and chair of the Hematopathology Section of the Association for Molecular Pathology. He also actually enjoys looking at non-specific skin inflammatory infiltrates and making sporadically correct guesses on etiology – safe in the knowledge that molecular testing will someday soon resolve all dermatopathology diagnostic dilemmas.